To order this 500+ page report, please visit
this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html
Key Inclusions
§
An overview of the current market landscape of digital
therapeutic solutions, including information on status of development, type of solution
(combination offering of software
application + device or AI or personal coach, and standalone software
application), type of therapy (curative
and preventive), purpose of solution (medication replacement and medication
augmentation), target disease indication(s), therapeutic area(s),
and target population. In addition, it presents details of the companies
developing digital therapeutic solution, highlighting year of establishment,
company size, type of business model used (B2B and B2C) and location of headquarters.
§
An in depth analysis of the contemporary market trends,
presented using four schematic representations, including [A] a bubble analysis
comparing the leading players engaged in the development of digital therapeutic
solutions based on the parameters, such as product portfolio strength, number
of target disease indication(s) and company size, [B] a grid representation
illustrating the distribution of the digital therapeutic solutions based on
status of development, type of solution and therapeutic area, [C] an insightful
tree map representation of the digital therapeutic solutions, distributed on
the basis of therapeutic area and company size, and [D] a world map
representation highlighting the regional distribution of developer companies.
§ A detailed product
competitiveness analysis of digital therapeutic solutions developed / under
development for the most popular therapeutic areas taking into consideration
the strength of product portfolio (based on the total number of digital
therapeutic solutions being developed in that disease area) and key product
specific parameters, such as status of development, type of solution, type of
therapy, and purpose of solution.
§
Elaborate profiles of prominent
small-sized and mid-sized players that are either engaged in the development or
have developed digital therapeutic solutions. Each company profile features a
brief overview of the company (with information on year of establishment,
number of employees, location of headquarters and key members of the executive
team), details of their respective product portfolio, recent developments and
an informed future outlook.
§
A detailed analysis of more than 220 completed, ongoing and
planned clinical studies of various digital therapeutic solutions, based on the
various relevant parameters, such as trial registration year, trial phase,
number of patients enrolled, study design, trial recruitment status and trial
focus, highlighting leading sponsors and leading digital therapeutic solutions
(in terms of number of trials conducted),
type of organization, popular therapeutic areas and regional distribution of
trials. In addition, it features an insightful clinical end-points analysis (for
trials initiated since 2018 for popular therapeutic areas).
§
An analysis of the investments made in the period between
2009 and 2020 (till June), including seed financing, venture capital
financing, debt financing, grants, capital raised from IPOs and subsequent
offerings, at various stages of development in companies that are engaged in this
field.
§
An analysis of the partnerships that have been inked by
stakeholders in this domain, in the period between 2008 and 2020 (till May),
covering clinical trial agreements, pilot product offerings, product
integration agreements, product launch agreements, product / technology
licensing agreements, marketing and distribution agreements, mergers /
acquisitions, and research and development agreements.
§
A detailed analysis of the various business models and
go-to-market strategies adopted by companies involved in this space, providing
details on various channels adopted / being adopted by stakeholders in the
industry to raise awareness and offer access to their proprietary products.
§
A Bowman’s Strategy Clock framework in order to analyze the
competitive position of various companies in the marketplace, taking into
consideration the prices and different features of their products.
§
An insightful discussion on the impact of COVID-19 pandemic
on the overall digital therapeutic solutions market, and the key initiatives
undertaken by big pharma players.
§
A review of the key aspects related to the remote digital
monitoring and diagnostics solutions, including [A] a brief introduction to
remote digital monitoring and diagnostics solutions, highlighting the key benefits
and roadblocks [B] an assessment of the market landscape of remote digital
monitoring and diagnostics solutions, based on various parameters, such as
status of development, type of solution, target disease indication(s) and
therapeutic area, along with details on the companies that develop these
solutions, highlighting year of establishment, company size and location of
headquarters [C] detailed profiles of some of the key players that presently
offer digital monitoring / diagnostic solutions for chronic disease management;
each profile features a brief overview of the company (with information on year of establishment, number of employees,
location of headquarters, lead investors, key partners and members of the executive team),
details of their product portfolio, recent developments and an informed future
outlook, and [D] an insightful analysis on various capital investments that
have been made into the digital monitoring / diagnostics domain.
§
A discussion on affiliated trends, key drivers and
challenges, under a SWOT framework, which are likely to impact the industry’s
evolution, including a Harvey ball analysis, highlighting the relative effect
of each SWOT parameter on the overall digital therapeutic solutions industry.
§
An informative analysis of contemporary Google Trends in
the time period between 2015 and 2020 (till July) and insights from the
recent news articles related digital therapeutic solutions, indicating the
increasing popularity of this domain. Furthermore, it highlights the potential
future opportunities for players engaged in development of such solutions.
The report also features the
likely distribution of the current and forecasted opportunity across important
market segments, mentioned below:
§
Type of Solution
§
Standalone Software
Application
§
Software Application
+ Device + Personal Coach
§
Software Application
+ Device + AI Support
§
Software Application
+ Device
§
Software Application
+ AI Support
§
Software Application
+ Personal Coach
§
Other Types of
Solutions
§
Purpose of Solution
§
Medication
Replacement
§
Medication
Augmentation
§
Type of Therapy
§
Curative
§
Preventive
§
Business Model
§
Business to Consumer
(Patients and Caregivers)
§
Business to Business
(Healthcare Providers, Payers, Employers and
Pharmaceutical Companies)
§
Therapeutic Areas
§
Cardiovascular
Disorders
§
Chronic Pain
§
Mental Health
Problems
§
Metabolic Disorders
§
Neurological
Disorders
§
Respiratory Disorders
§
Sleep Disorders
§
Substance Use
Disorders
§
Others
§
Key Geographical
Regions
§
North America
§
Europe
§
Asia-Pacific
§
Rest of the
world
The
report includes detailed transcripts of discussions held with the following
experts:
§
Eran Ofir (Co-Founder
and Chief
Executive Officer, Somatix)
§
Edouard Gasser
(Co-Founder and Chief Executive Officer, Tilak Healthcare)
§
Stephanie Tilenius
(Co-Founder
and Chief Executive Officer, Vida Health)
§
Adam Kaufman (Chief Executive
Officer, Canary
Health)
§
Vijay Ravindran (Chief Executive
Officer, Floreo)
§
Palakh R Sarogi (Vice
President, Marketing, Wellthy Therapeutics),
Arani Sarkra (Senior Manager, Consumer Marketing, Wellthy Therapeutics)
and Yolande D’Mello (Marketing and Public Relations, Wellthy Therapeutics)
§
Amelie Janson
(Communication Manager, Voluntis)
§
Anonymous (Founder
and Chief Executive Officer, UK based Small-sized Company)
To request sample pages, please visit this - https://www.rootsanalysis.com/reports/208/request-sample.html
Key Questions Answered
§
Who are the leading developers offering digital therapeutic
solutions?
§
What are the most popular therapeutic areas for digital
therapeutic solutions?
§
Which companies are actively involved in conducting clinical
trials for their solutions?
§
What are the key factors influencing the price of digital
therapeutic solutions?
§
What is the trend in capital investments in the digital
therapeutics market?
§
Which partnership models are commonly adopted by stakeholders in
this industry?
§
What type of marketing strategies are being adopted by developers
in this domain?
§
What is the impact of COVID-19 outbreak on digital therapeutic
solutions market?
§
What are the opportunities for digital therapeutic solutions in
emerging markets?
§
How is the current and future opportunity likely to be
distributed across key market segments?
§
What are the anticipated future trends related to digital
therapeutic solutions market?
You
may also be interested in the following titles:
1. AR /
VR Based Healthcare Digital Marketing Service Providers
Market, 2020-2030
2. AI-Based
Clinical Trial Solution Providers Market, 2020-2030
3.
Global
Handheld Ultrasound Imaging Devices Market, 2020-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
